CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (USD $)	SeriesAPreferredStockMember	Common Stock	Additional Paid-In Capital	Treasury Stock	Notes Receivable from Sale of Stock	Deficit accumulated during the development stage	Total
Beginning Balance, Amount at May. 25, 1998
Beginning Balance, Shares at May. 25, 1998
Initial sale of common stock for cash to Founder, Amount		1,000	4,000				5,000
Initial sale of common stock for cash to Founder, Shares		1,000,000
Fair value of common stock issued for services, Amount		400	400				400
Fair value of common stock issued for services, Shares		4,000
Effect of the Merger, Amount		1,600	(1,600)
Effect of the Merger, Shares		1,569,000
Net Loss						(230,900)	(230,900)
Ending Balance, Amount at Mar. 31, 1999		2,600	2,800			(230,900)	(225,500)
Ending Balance, Shares at Mar. 31, 1999		2,573,000
Fair value of common stock issued for services, Amount		100	21,800				21,900
Fair value of common stock issued for services, Shares		104,375
Sale of common stock for cash, Amount		200	19,800				20,000
Sale of common stock for cash, Shares		200,000
Fair value of warrants issued for services			39,500				39,500
Net Loss						(700,000)	(700,000)
Ending Balance, Amount at Mar. 31, 2000		2,900	83,900			(930,900)	(844,100)
Ending Balance, Shares at Mar. 31, 2000		2,877,375
Fair value of common stock issued for services, Amount		100	32,900				33,000
Fair value of common stock issued for services, Shares		100,000
Fair value of warrants issued for services			13,100				13,100
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount			4,600				4,600
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		14,000
Proceeds allocated to warrants issued in connection with 7% convertible notes			91,200				91,200
Net Loss						(1,809,000)	(1,809,000)
Ending Balance, Amount at Mar. 31, 2001		3,000	225,700			(2,739,900)	(2,511,200)
Ending Balance, Shares at Mar. 31, 2001		2,991,375
Fair value of warrants issued for services			33,100				33,100
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount			500				500
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		1,511
Proceeds allocated to warrants issued in connection with 10% convertible notes			7,300				7,300
Net Loss						(2,113,000)	(2,113,000)
Ending Balance, Amount at Mar. 31, 2002		3,000	266,600			(4,852,900)	(4,583,300)
Ending Balance, Shares at Mar. 31, 2002		2,992,886
Fair value of warrants issued for services			46,500				46,500
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount		0	5,000				5,000
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		15,000
Proceeds allocated to warrants issued in connection with 10% convertible notes			86,800				86,800
Net Loss						(502,600)	(502,600)
Ending Balance, Amount at Mar. 31, 2003		3,000	404,900			(5,355,500)	(4,947,600)
Ending Balance, Shares at Mar. 31, 2003		3,007,886
Fair value of warrants issued for services			2,200				2,200
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount			600				600
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		2,925
Proceeds allocated to warrants issued in connection with 10% convertible notes			11,400				11,400
Net Loss						(8,755,500)	(8,755,500)
Ending Balance, Amount at Mar. 31, 2004		3,000	419,100			(14,111,000)	(13,688,900)
Ending Balance, Shares at Mar. 31, 2004		3,010,811
Fair value of warrants issued for services			1,500				1,500
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount			4,800				4,800
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		10,708
Proceeds allocated to warrants issued in connection with Series C Preferred stock			25,500				25,500
Net Loss						(1,082,800)	(1,082,800)
Ending Balance, Amount at Mar. 31, 2005		3,000	450,900			(15,193,800)	(14,739,900)
Ending Balance, Shares at Mar. 31, 2005		3,021,519
Fair value of warrants issued for services			3,300				3,300
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount			6,600				6,600
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		14,604
Net Loss						(1,772,100)	(1,772,100)
Ending Balance, Amount at Mar. 31, 2006		3,000	460,800			(16,965,900)	(16,502,100)
Ending Balance, Shares at Mar. 31, 2006		3,036,123
Sale of common stock for cash, Amount			1,000				1,000
Sale of common stock for cash, Shares		10,000
Fair value of warrants issued for services			3,100				3,100
Common stock issued upon exercise of options from 1999 Stock Incentive Plan and warrants for: Cash, Amount		100	27,600				27,700
Common stock issued upon exercise of options from 1999 Stock Incentive Plan and warrants for: Cash, Shares		33,465
Common stock issued upon exercise of options from 1999 Stock Incentive Plan and warrants for: Debt cancellation, Amount		100	112,700				112,800
Common stock issued upon exercise of options from 1999 Stock Incentive Plan and warrants for: Debt cancellation, Shares		108,418
Common stock issued upon exercise of options from 1999 Stock Incentive Plan and warrants for: Notes receivable, Amount		200	149,600		(149,800)
Common stock issued upon exercise of options from 1999 Stock Incentive Plan and warrants for: Notes receivable, Shares		204,498
Share-based compensation expense			109,800				109,800
Forgiveness of accrued compensation and accrued interest payable to officers			799,900				799,900
Net Loss						(1,999,800)	(1,999,800)
Ending Balance, Amount at Mar. 31, 2007		3,400	1,664,500		(149,800)	(18,965,700)	(17,447,600)
Ending Balance, Shares at Mar. 31, 2007		3,392,504
Fair value of warrants issued for services			224,000				224,000
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount			1,900				1,900
Common stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		2,234
Share-based compensation expense			247,600				247,600
Common stock issued upon settlement of employment contract, Amount			42,000				42,000
Common stock issued upon settlement of employment contract, Shares		20,000
Proceeds allocated to warrants issued in connection with Platinum Notes			221,000				221,000
Accrued interest on notes receivable					(9,200)		(9,200)
Net Loss						(5,446,700)	(5,446,700)
Ending Balance, Amount at Mar. 31, 2008		3,400	2,401,000		(159,000)	(24,412,400)	(22,167,000)
Ending Balance, Shares at Mar. 31, 2008		3,414,738
Fair value of warrants issued for services			5,300				5,300
Share-based compensation expense			108,200				108,200
Accrued interest on notes receivable					(7,900)		(7,900)
Common stock issued upon exercise of options from 2008 Stock Incentive Plan and Scientific Advisory Plan, Amount			1,000				1,000
Common stock issued upon exercise of options from 2008 Stock Incentive Plan and Scientific Advisory Plan, Shares		3,500
Proceeds allocated to warrants issued in connection with Platinum Notes and incremental fair value of warrant modification			72,700				72,700
Effect of reverse stock split		(6)
Net Loss						(4,696,200)	(4,696,200)
Ending Balance, Amount at Mar. 31, 2009		3,400	2,588,200		(166,900)	(29,108,600)	(26,683,900)
Ending Balance, Shares at Mar. 31, 2009		3,418,232
Share-based compensation expense			668,500				668,500
Accrued interest on notes receivable					(8,400)		(8,400)
Cumulative effect of adopting new accounting standard			(293,700)			142,300	(151,400)
Common stock issued upon exercise of warrant, Amount			100				100
Common stock issued upon exercise of warrant, Shares		1,086
Common stock issued for cancellation of accounts payable and accrued interest, Amount		1,600	2,468,600				2,470,200
Common stock issued for cancellation of accounts payable and accrued interest, Shares		1,646,792
Incremental fair value of note conversion options from debt modification			828,500				828,500
Common stock issued for services, Amount		200	262,300				262,500
Common stock issued for services, Shares		175,000
Fair value of warrants issued for services and incremental fair value of warrant modification			110,100				110,100
Fair value of warrants issued in connection with 7.5% Notes			291,200				291,200
Net Loss						(4,124,500)	(4,124,500)
Ending Balance, Amount at Mar. 31, 2010		5,200	6,923,800		(175,300)	(33,090,800)	(26,337,100)
Ending Balance, Shares at Mar. 31, 2010		5,241,110
Share-based compensation expense			1,628,800				1,628,800
Accrued interest on notes receivable					(8,800)		(8,800)
Incremental fair value of note conversion options from debt modification			1,062,800				1,062,800
Fair value of warrants issued in connection with the August 2010 Short-Term Notes			252,000				252,000
Net Loss						(9,482,200)	(9,482,200)
Ending Balance, Amount at Mar. 31, 2011		5,200	9,867,400		(184,100)	(42,573,000)	(32,884,500)
Beginning Balance, Shares at Mar. 31, 2011		5,241,110
Fair value of warrants issued for services			564,500				564,500
Share-based compensation expense			1,591,300				1,591,300
Accrued interest on notes receivable						(1,000)	(1,000)
Reclassification of warrant liability to equity			424,100				424,100
Incremental value of Platinum note modification			1,070,600				1,070,600
Incremental value of Morrison Foerster warrant modification			58,700				58,700
Stock issued in May 2011 Private Placement, net of $202,000 placement fees, Amount		2,200	3,674,000		(500,000)		3,176,200
Stock issued in May 2011 Private Placement, net of $202,000 placement fees, Shares		2,216,106
Payments on note receivable for sale of stock					250,000		250,000
Stock issued upon conversion of convertible promissory notes, Amount		3,500	6,171,300				6,174,800
Stock issued upon conversion of convertible promissory notes, Shares		3,528,290
Stock issued upon conversion of all series of preferred stock, Amount		2,900	14,531,900				14,534,800
Stock issued upon conversion of all series of preferred stock, Shares		2,884,655
Fair value of stock issued for services prior to the Merger, Amount		1,400	2,224,100				2,225,500
Fair value of stock issued for services prior to the Merger, Shares		1,371,743
Forgiveness of notes at the Merger, Amount					185,100		185,100
Forgiveness of notes at the Merger, Shares
Stock issued upon exercise of modified warrants (includes Platinum exercises), Amount		3,100	3,426,200				3,429,300
Stock issued upon exercise of modified warrants (includes Platinum exercises), Shares		3,121,259
Incremental value of warrant modifications (including modification of Platinum warrants)			1,028,900				1,028,900
Fair value of bonus warrants under Discounted Warrant Exercise Program			138,100				138,100
Stock issued in Fall 2011 Follow-on Offering, Amount		100	111,200				111,300
Stock issued in Fall 2011 Follow-on Offering, Shares		63,570
Stock issued upon exercise of options from 1999 Stock Incentive Plan, Amount		100	102,100				102,200
Stock issued upon exercise of options from 1999 Stock Incentive Plan, Shares		113,979
Fair value of stock issued for services following the Merger, Amount		200	451,800				452,000
Fair value of stock issued for services following the Merger, Shares		155,555
Placement fees on 12% Convertible Notes
Proceeds allocated to warrants issued and beneficial conversion feature in connection with 12% convertible notes			461,700				461,700
Stock issued in connection with note term extension, Amount			22,400				22,400
Stock issued in connection with note term extension, Shares		8,000
Stock issued upon conversion of Platinum Note to equity (net of Platinum warrant exercise reflected above), Amount	200		3,387,700				3,387,900
Stock issued upon conversion of Platinum Note to equity (net of Platinum warrant exercise reflected above), Shares	231,090
Common stock exchanged for Series A Preferred under agreements with Platinum: Common Stock Exchange Agreement, Amount			750,600	(750,600)
Common stock exchanged for Series A Preferred under agreements with Platinum: Common Stock Exchange Agreement, Shares	45,980
Common stock exchanged for Series A Preferred under agreements with Platinum: Note and Warrant Exchange Agreement, Amount	200		2,480,900	(2,481,100)
Common stock exchanged for Series A Preferred under agreements with Platinum: Note and Warrant Exchange Agreement, Shares	159,985
Net Loss						(12,209,500)	(12,209,500)
Ending Balance, Amount at Mar. 31, 2012	400	18,700	52,539,500	(3,231,700)	(250,000)	(54,782,500)	(5,705,600)
Ending Balance, Shares at Mar. 31, 2012	437,055	18,704,267
Fair value of common stock issued for services, Amount		400	339,600				339,600
Fair value of common stock issued for services, Shares		400,000
Fair value of warrants issued for services			106,200				106,200
Share-based compensation expense			1,241,300				1,241,300
Incremental value of Morrison Foerster warrant modification			998,500				998,500
Payments on note receivable for sale of stock					66,900		66,900
Stock issued upon exercise of modified warrants (includes Platinum exercises), Amount		500	274,000				274,500
Stock issued upon exercise of modified warrants (includes Platinum exercises), Shares		549,056
Incremental value of warrant modifications (including modification of Platinum warrants)			440,700				440,700
Common stock exchanged for Series A Preferred under agreements with Platinum: Common Stock Exchange Agreement, Amount	100		736,300	(736,400)
Common stock exchanged for Series A Preferred under agreements with Platinum: Common Stock Exchange Agreement, Shares	62,945
Fair value of warrants issued upon exercise of modified warrants			35,900				35,900
Fair value of shares issued in settlement of accounts payable, amount		100	103,100				103,200
Fair value of shares issued in settlement of accounts payable, shares		103,235
Modification of note receivable from sale of stock					(26,000)		(26,000)
Fair value of warrant issued to Cato Holding Company in connection with note payable restructure			120,500				120,500
Fair value of warrant issued to Cato Holding Company in connection with accounts payable restructure			486,200				486,200
Fair value of warrant issued to University Health Network in connection with accounts payable restructure			264,800				264,800
Fair value of warrants issued to Morrison & Foerster, Cato Reearch Ltd. and University Health Network in connection with accrued interest on underlying notes			49,400				49,400
Sale of Units in Winter 2012 Private Placement, net, Amount		2,400	1,246,600				1,249,000
Sale of Units in Winter 2012 Private Placement, net, Shares		2,366,330
Exchange of February 2012 convertible notes, Amount		1,400	1,214,200				1,215,600
Exchange of February 2012 convertible notes, Shares		1,357,281
Fair value of warrants issued to banker in connection with exchange of February 2012 convertible notes			28,200				28,200
Premium of fair value over face value of Exchange Note issued to PLatinum			1,083,200				1,083,200
Fair value of Series A Exchange Warrant issuable to Platinum recorded as a Warrant Liability			(3,068,200)				(3,068,200)
Proceeds allocated to beneficial conversion feature of Investment Notes issued to PLatinum in October 2012, February 2013 and March 2013			958,500				958,500
Incremental fair value of warrant modifications in Feburary 2013			67,500				67,500
Net Loss						(12,886,700)	(12,886,700)
Ending Balance, Amount at Mar. 31, 2013	$ 500	$ 23,500	$ 59,266,000	$ (3,968,100)	$ (209,100)	$ (67,669,200)	$ (12,556,400)
Ending Balance, Shares at Mar. 31, 2013	500,000	23,480,169